---
content_type: resource
description: Gleevec (in red) is a drug used to treat chronic myeloid leukemia (CML).
  It works by inhibiting bcr-abl kinase (in green), the protein that causes CML. (Image
  courtesy of RCSB Protein Data Bank entry 1IEP.)
file: null
file_location: /coursemedia/7-341-bench-to-bedside-molecularly-targeted-therapies-in-blood-disorders-and-malignancy-fall-2009/5d6d01e4b56a83cf06760537410e1ca7_7-341f09-th.jpg
file_type: image/jpeg
resourcetype: Image
title: Ribbon diagram of the crystal structure of BCR-ABL kinase in complex with Gleevec
uid: 5d6d01e4-b56a-83cf-0676-0537410e1ca7
---
